Abstract:Obesity activates both innate and adaptive immune responses in adipose tissue. Elevated levels of eosinophils with depression of monocyte and neutrophil indicate the deficiencies in the immune system of morbidly obese individuals. Actually, adipose tissue macrophages are functional antigen-presenting cells that promote the proliferation of interferon-gamma (IFN-gamma)-producing CD4+ T cells in adipose tissue of obese subjects. Eventually, diet-induced obesity is associated with the loss of tissue homeostasis and development of type 1 inflammatory responses in visceral adipose tissue. Activity of inducible indoleamine 2,3-dioxygenase-1 (IDO-1) plays a major role under pro-inflammatory, IFN-gamma dominated settings. One of the two rate-limiting enzymes which can metabolize tryptophan to kynurenine is IDO-1. Tumor necrosis factor-alpha (TNF-alpha) correlates with IDO-1 in adipose compartments. Actually, IDO-1-mediated tryptophan catabolism due to chronic immune activation is the cause of reduced tryptophan plasma levels and be considered as the driving force for food intake in morbidly obese patients. Thus, decrease in plasma tryptophan levels and subsequent reduction in serotonin (5-HT) production provokes satiety dysregulation that leads to increased caloric uptake and obesity. However, after bariatric surgery, weight reduction does not lead to normalization of IDO-1 activity. Furthermore, there is a connection between arginine and tryptophan metabolic pathways in the generation of reactive nitrogen intermediates. Hence, abdominal obesity is associated with vascular endothelial dysfunction and reduced nitric oxide (NO) availability. IFN-gamma-induced activation of the inducible nitric oxide synthase (iNOS) and dissociation of endothelial adenosine monophosphate activated protein kinase (AMPK)- phosphoinositide 3-kinase (PI3K)-protein kinase B (Akt)- endothelial NO synthase (eNOS) pathway enhances oxidative stress production secondary to high-fat diet. Thus, reduced endothelial NO availability correlates with the increase in plasma non-esterified fatty acids and triglycerides levels. Additionally, in obese patients, folate-deficiency leads to hyperhomocysteinemia. Folic acid confers protection against hyperhomocysteinemia-induced oxidative stress.

Unravelling metabolic factors impacting iNKT cell biology in obesity

Contribution of NKT cells and CD1d-expressing cells in obesity-associated adipose tissue inflammation

NK cell-activating receptor NKp46 does not participate in the development of obesity-induced inflammation and insulin resistance

Phenotypic Diversity of Human Adipose Tissue-Resident NK Cells in Obesity

Dysregulated cytokine and oxidative response in hyper-glycolytic monocytes in obesity

Obesity-Mediated Immune Modulation: One Step Forward, (Th)2 Steps Back

The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity

Activation of Natural Killer T Cells Promotes M2 Macrophage Polarization in Adipose Tissue and Improves Systemic Glucose Tolerance Via Interleukin-4 (IL-4)/STAT6 Protein Signaling Axis in Obesity*

Immune Regulation in Obesity-Associated Adipose Inflammation

Enhanced Glycogen Synthase Kinase 3β phosphorylation modulates leukocytes Toll-like receptor-mediated cytokine secretion in obese people. (180.7)

Cell-cell crosstalk between fat cells and immune cells

T cells in obesity‐associated inflammation: The devil is in the details

Immunometabolic Signatures of Circulating Monocytes in Humans with Obesity and Insulin Resistance

Obesity Modulates Intestinal Intraepithelial T Cell Persistence, CD103 and CCR9 Expression, and Outcome in Dextran Sulfate Sodium-Induced Colitis

Tissue Immune Cells Fuel Obesity-Associated Inflammation in Adipose Tissue and Beyond

Innate lymphoid cells type 2 - emerging immune regulators of obesity and atherosclerosis

Immunometabolism and natural killer cell responses

Epigenetic Reprogramming of the Inflammatory Response in Obesity and Type 2 Diabetes

Lipid accumulation in adipose tissue-resident iNKT cells contributes to an inflammatory phenotype

Role of Innate lymphoid Cells in Obesity and Insulin Resistance

Regulation of metabolism by the innate immune system